Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fejgin

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1987
Nodular malignant lymphoma presenting as bilateral adnexal massesI Cohen, M Fejgin, I Ben-Nun, et al.
Cancer Genetics and Cytogenetics|August 25, 1999
Deletion 5q31 in patients with stable, melphalan-treated multiple myelomaA Amiel, K Fridman, A Elis, et al.
Cancer Genetics and Cytogenetics|March 4, 2000
Multiple myeloma: monoallelic deletions of the tumor suppressor genes TP53 and RB1 in long-term follow-upM Carlebach, A Amiel, E Gaber, et al.
Cancer Genetics and Cytogenetics|September 1, 1995
Fluorescence in situ hybridization (FISH) for retrospective detection of trisomies 3 and 7 in multiple myelomaR Dubinsky, A Amiel, Y Manor, et al.
Cancer Genetics and Cytogenetics|January 1, 1993
Clinical detection of BCR-abl fusion by in situ hybridization in chronic myelogenous leukemiaA Amiel, S Yarkoni, M Fejgin, et al.
Obstetrical & Gynecological Survey|March 1, 1996
Differential diagnosis and management of very low second trimester maternal serum unconjugated estriol levels, with special emphasis on the diagnosis of X-linked ichthyosisY Zalel, I Kedar, R Tepper, et al.
Cancer Genetics and Cytogenetics|July 18, 2006
Random aneuploidy in CML patients at diagnosis and under imatinib treatmentA Amiel, M Yukla, E Gaber, et al.
Gynecologic and Obstetric Investigation|January 1, 1994
Estrogen replacement in postmenopausal women: are we currently overdosing our patients?R Tepper, S Goldberger, I Cohen, et al.
Cancer Genetics and Cytogenetics|September 1, 1997
Monoallelic p53 deletion in chronic lymphocytic leukemia detected by interphase cytogeneticsA Amiel, L Arbov, Y Manor, et al.
Cancer Genetics and Cytogenetics|August 1, 1994
Detection of minimal residual disease state in chronic myelogenous leukemia patients using fluorescence in situ hybridizationA Amiel, S Yarkoni, S Slavin, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1987
Nodular malignant lymphoma presenting as bilateral adnexal massesI Cohen, M Fejgin, I Ben-Nun, et al.
Cancer Genetics and Cytogenetics|August 25, 1999
Deletion 5q31 in patients with stable, melphalan-treated multiple myelomaA Amiel, K Fridman, A Elis, et al.
Cancer Genetics and Cytogenetics|March 4, 2000
Multiple myeloma: monoallelic deletions of the tumor suppressor genes TP53 and RB1 in long-term follow-upM Carlebach, A Amiel, E Gaber, et al.
Cancer Genetics and Cytogenetics|September 1, 1995
Fluorescence in situ hybridization (FISH) for retrospective detection of trisomies 3 and 7 in multiple myelomaR Dubinsky, A Amiel, Y Manor, et al.
Cancer Genetics and Cytogenetics|January 1, 1993
Clinical detection of BCR-abl fusion by in situ hybridization in chronic myelogenous leukemiaA Amiel, S Yarkoni, M Fejgin, et al.
Obstetrical & Gynecological Survey|March 1, 1996
Differential diagnosis and management of very low second trimester maternal serum unconjugated estriol levels, with special emphasis on the diagnosis of X-linked ichthyosisY Zalel, I Kedar, R Tepper, et al.
Cancer Genetics and Cytogenetics|July 18, 2006
Random aneuploidy in CML patients at diagnosis and under imatinib treatmentA Amiel, M Yukla, E Gaber, et al.
Gynecologic and Obstetric Investigation|January 1, 1994
Estrogen replacement in postmenopausal women: are we currently overdosing our patients?R Tepper, S Goldberger, I Cohen, et al.
Cancer Genetics and Cytogenetics|September 1, 1997
Monoallelic p53 deletion in chronic lymphocytic leukemia detected by interphase cytogeneticsA Amiel, L Arbov, Y Manor, et al.
Cancer Genetics and Cytogenetics|August 1, 1994
Detection of minimal residual disease state in chronic myelogenous leukemia patients using fluorescence in situ hybridizationA Amiel, S Yarkoni, S Slavin, et al.
Pageof 9